Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

Recalls / Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA

Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA

Drugs · Last updated 2018-09-10

Why it was recalled

New safety information

Source

Other Recent Recalls

Apo-Semaglutide Injection

Apo-Semaglutide Injection : Incorrect dose display

Type II2026-09-24

Moderate health risk

Novo-Gesic Forte 500 mg tablets (acetaminophen)

Generic acetaminophen by Teva recalled because it may contain foreign material

Type I2026-09-10

Highest health risk

JAMP Temozolomide

JAMP Temozolomide: Out-of-Specification (Assay)

Type II2026-08-31

Moderate health risk

Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.